In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and development into the next decade, according to a BCC Research report.

India, the world’s pharmacy for low-cost generics, is attempting a major upgrade. The Department of Pharmaceuticals has opened applications for the ₹5,000 crore program aimed at funding research and ...

In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, ...

US President Trump’s recent announcement of a 100 percent tariff on import of branded and patented pharma products, starting October 1, has rattled the global supply chains of drugmakers. While ...